Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
30–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy males or healthy postmenopausal females, including Japanese participants
Body mass index (BMI) of 18 and 35 kilograms per square meter (kg/m\^2), inclusive
You may not be if
Abnormal siting blood pressure as determined by the investigator
Abnormality in the 12-lead electrocardiogram (ECG) that, in the opinion of the investigator, places the participant at an unacceptable risk for study participation
Aspartate aminotransferase (AST) or alkaline phosphatase (ALT) greater than 2 times the upper limit of normal (ULN)
Skin condition that in the opinion of the investigator makes the participant unsuitable for study participation
Current use of statins within the last 3 months prior to dosing
Current use or previous use of anabolic steroids in the preceding 6 months prior to dosing
Use of dehydroepiandrosterone, other potential over-the-counter steroidal supplements, or other nutritional products intended to have weight-reduction and/or performance-enhancing effects within 21 days prior to dosing
